未知股票 EFTR 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 470.44万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 6.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%
EFFECTOR Therapeutics shares are trading lower by 74% during Monday's session. The company announced that it has terminated its employees and will wind down its operations.
2024-06-24 23:26
eFFECTOR Therapeutics Initiates Wind-Down and Leadership Change
The latest update is out from eFFECTOR Therapeutics (EFTR). eFFECTOR Therapeuti...
2024-06-24 20:56
eFFECTOR Therapeutics GAAP EPS of -$2.16 beats by $0.01
eFFECTOR Therapeutics press release (NASDAQ:EFTR): Q1 GAAP EPS of -$2.16 beats by $0.01. $15.0 million in gross proceeds raised from registered direct financing, extending cash runway into the first q...
2024-05-10 18:33
EFFECTOR Therapeutics to Participate in Upcoming Investor Conference
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) ...
2024-04-09 20:00
Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), uniQure (QURE) and eFFECTOR Therapeutics (EFTR)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
2024-04-09 10:20
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P 500 also rose, gaining, 0.75% to 5,250.72.
2024-04-04 23:58
Effector Therapeutics’ Stock Issuance Capped: Navigating the Lincoln Park Agreement’s Exchange Limit
Effector Therapeutics, Inc. (EFTR) has disclosed a new risk, in the Share Price...
2024-03-27 14:01
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers
Gainers: Stoke Therapeutics (STOK) +79%. Mesoblast ADR (MESO) +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines (PRAX) +25%. Check-Cap (CHEK) +23%. Losers: NeuBase Therapeutics (NBSE) -54%....
2024-03-26 22:00
GOEV, NBSE and FLGC among pre-market losers
Losers: NeuBase Therapeutics (NBSE) -58%. AppTech Payments Corp (APCX) -41% announces proposed underwritten public offering. Ampio Pharmaceuticals (AMPE) -38% announces voluntary delisting and SEC der...
2024-03-26 20:15
eFFECTOR Therapeutics Announces $15M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) (the "Company"), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that it has entered into a
2024-01-25 21:11
